Mammography screening does not save many women's lives, reports a new study. It just provides early diagnosis with no impact on mortality or it over diagnoses disease.
Mammography screening does not save many women's lives, reports a new study. It just provides early diagnosis with no impact on mortality or it over diagnoses disease.
Using DevCan 6.5.0, which the National Cancer Institute uses in estimating 10-year risk of diagnosis and 20-year risk of death, researchers at Dartmouth College developed a method to calculate the probability that a woman with screen-detected breast cancer has had her life saved by screening.
They determined that a 50-year-old woman has an estimated risk for having screen-detected breast cancer in the next 10 years of 1,910 per 100,000. Her observed 20-year risk for breast cancer is 990 per 100,000. Assuming that mammography reduces her risk for breast cancer by 20%, the risk for death without screening would be 1,240 per 100,000, suggesting that 250 per 100,000 women are spared. Thus, the likelihood that a woman with screen-detected breast cancer avoids death from her disease because of the screening is 13%. If screening mammography reduces breast cancer mortality by 5%, then the death benefit is only 3%. Analyses of women of different ages all yielded probability estimates below 25%.
Welch HG, Frankel BA. Likelihood that a woman with screen-detected breast cancer has had her "life saved" by that screening. Arch Intern Med. October 24, 2011. (Epub ahead of print.)
Fasting glucose at GDM diagnosis may predict postpartum glucose abnormalities
February 6th 2025A recent study suggests that elevated fasting glucose levels at the time of gestational diabetes diagnosis could be an early indicator of postpartum glucose intolerance, emphasizing the need for close monitoring after delivery.
Read More
Ulipristal plus misoprostol shows promise for medication abortion
February 5th 2025A recent study found that ulipristal acetate followed by misoprostol is a safe, effective, and acceptable option for medication abortion, offering a potential alternative in areas with limited access to mifepristone.
Read More
Identification and management of patients at increased risk for breast cancer
February 5th 2025With breast cancer being the most diagnosed invasive cancer in the United States, OB-GYN practitioners play a crucial role in identifying high-risk patients and guiding them through screening, prevention, and risk-reduction strategies.
Read More